EUVIMEDEUVIMED entdecken
Kommentar

Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma

Stephen M Ansell

JAMA · 19.05.2026 · 335 (19) · 1669

DOI: 10.1001/jama.2026.4291 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA, erschienen am 19.05.2026. Verfasst von Stephen M Ansell. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, Minnesota. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, Minnesota.

Zitieren

APA

Ansell, S. M. (2026). Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA, 335(19), 1669. https://doi.org/10.1001/jama.2026.4291

Vancouver

Ansell SM. Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA. 2026;335(19):1669. doi:10.1001/jama.2026.4291

BibTeX
@article{Ansell2026,
  author = {Ansell, Stephen M},
  title = {Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {19},
  pages = {1669},
  doi = {10.1001/jama.2026.4291}
}
Kostenlos starten →